The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review

(1) Background: Up to 50% of patients with colorectal cancer either have synchronous colorectal liver metastases (CRLM) or develop CRLM over the course of their disease. Surgery and thermal ablation are the most common local treatment options of choice. Despite development and improvement in local t...

Full description

Bibliographic Details
Main Authors: Okker D. Bijlstra, Maud M. E. Boreel, Sietse van Mossel, Mark C. Burgmans, Ellen H. W. Kapiteijn, Daniela E. Oprea-Lager, Daphne D. D. Rietbergen, Floris H. P. van Velden, Alexander L. Vahrmeijer, Rutger-Jan Swijnenburg, J. Sven D. Mieog, Lioe-Fee de Geus-Oei
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/3/715
_version_ 1827649309203496960
author Okker D. Bijlstra
Maud M. E. Boreel
Sietse van Mossel
Mark C. Burgmans
Ellen H. W. Kapiteijn
Daniela E. Oprea-Lager
Daphne D. D. Rietbergen
Floris H. P. van Velden
Alexander L. Vahrmeijer
Rutger-Jan Swijnenburg
J. Sven D. Mieog
Lioe-Fee de Geus-Oei
author_facet Okker D. Bijlstra
Maud M. E. Boreel
Sietse van Mossel
Mark C. Burgmans
Ellen H. W. Kapiteijn
Daniela E. Oprea-Lager
Daphne D. D. Rietbergen
Floris H. P. van Velden
Alexander L. Vahrmeijer
Rutger-Jan Swijnenburg
J. Sven D. Mieog
Lioe-Fee de Geus-Oei
author_sort Okker D. Bijlstra
collection DOAJ
description (1) Background: Up to 50% of patients with colorectal cancer either have synchronous colorectal liver metastases (CRLM) or develop CRLM over the course of their disease. Surgery and thermal ablation are the most common local treatment options of choice. Despite development and improvement in local treatment options, (local) recurrence remains a significant clinical problem. Many different imaging modalities can be used in the follow-up after treatment of CRLM, lacking evidence-based international consensus on the modality of choice. In this systematic review, we evaluated <sup>18</sup>F-FDG-PET-CT performance after surgical resection, thermal ablation, radioembolization, and neoadjuvant and palliative chemotherapy based on current published literature. (2) Methods: A systematic literature search was performed on the PubMed database. (3) Results: A total of 31 original articles were included in the analysis. Only one suitable study was found describing the role of <sup>18</sup>F-FDG-PET-CT after surgery, which makes it hard to draw a firm conclusion. <sup>18</sup>F-FDG-PET-CT showed to be of additional value in the follow-up after thermal ablation, palliative chemotherapy, and radioembolization. <sup>18</sup>F-FDG-PET-CT was found to be a poor to moderate predictor of pathologic response after neoadjuvant chemotherapy. (4) Conclusions: <sup>18</sup>F-FDG-PET-CT is superior to conventional morphological imaging modalities in the early detection of residual disease after thermal ablation and in the treatment evaluation and prediction of prognosis during palliative chemotherapy and after radioembolization, and <sup>18</sup>F-FDG-PET-CT could be considered in selected cases after neoadjuvant chemotherapy and surgical resection.
first_indexed 2024-03-09T19:55:53Z
format Article
id doaj.art-5138590af9bd4509b30d021ef5c15f76
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-09T19:55:53Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-5138590af9bd4509b30d021ef5c15f762023-11-24T00:56:07ZengMDPI AGDiagnostics2075-44182022-03-0112371510.3390/diagnostics12030715The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic ReviewOkker D. Bijlstra0Maud M. E. Boreel1Sietse van Mossel2Mark C. Burgmans3Ellen H. W. Kapiteijn4Daniela E. Oprea-Lager5Daphne D. D. Rietbergen6Floris H. P. van Velden7Alexander L. Vahrmeijer8Rutger-Jan Swijnenburg9J. Sven D. Mieog10Lioe-Fee de Geus-Oei11Leiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The NetherlandsLeiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The NetherlandsSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Centre, 2333 ZA Leiden, The NetherlandsSection of Interventional Radiology, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The NetherlandsDepartment of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The NetherlandsDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center, 1081 HV Amsterdam, The NetherlandsSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Centre, 2333 ZA Leiden, The NetherlandsSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Centre, 2333 ZA Leiden, The NetherlandsLeiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The NetherlandsDepartment of Surgery, Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, 1081 HV Amsterdam, The NetherlandsLeiden University Medical Center, Department of Surgery, Albinusdreef 2, 2333 ZA Leiden, The NetherlandsSection of Nuclear Medicine, Department of Radiology, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands(1) Background: Up to 50% of patients with colorectal cancer either have synchronous colorectal liver metastases (CRLM) or develop CRLM over the course of their disease. Surgery and thermal ablation are the most common local treatment options of choice. Despite development and improvement in local treatment options, (local) recurrence remains a significant clinical problem. Many different imaging modalities can be used in the follow-up after treatment of CRLM, lacking evidence-based international consensus on the modality of choice. In this systematic review, we evaluated <sup>18</sup>F-FDG-PET-CT performance after surgical resection, thermal ablation, radioembolization, and neoadjuvant and palliative chemotherapy based on current published literature. (2) Methods: A systematic literature search was performed on the PubMed database. (3) Results: A total of 31 original articles were included in the analysis. Only one suitable study was found describing the role of <sup>18</sup>F-FDG-PET-CT after surgery, which makes it hard to draw a firm conclusion. <sup>18</sup>F-FDG-PET-CT showed to be of additional value in the follow-up after thermal ablation, palliative chemotherapy, and radioembolization. <sup>18</sup>F-FDG-PET-CT was found to be a poor to moderate predictor of pathologic response after neoadjuvant chemotherapy. (4) Conclusions: <sup>18</sup>F-FDG-PET-CT is superior to conventional morphological imaging modalities in the early detection of residual disease after thermal ablation and in the treatment evaluation and prediction of prognosis during palliative chemotherapy and after radioembolization, and <sup>18</sup>F-FDG-PET-CT could be considered in selected cases after neoadjuvant chemotherapy and surgical resection.https://www.mdpi.com/2075-4418/12/3/715positron emission tomographycolorectal cancercolorectal liver metastasesfollow-up
spellingShingle Okker D. Bijlstra
Maud M. E. Boreel
Sietse van Mossel
Mark C. Burgmans
Ellen H. W. Kapiteijn
Daniela E. Oprea-Lager
Daphne D. D. Rietbergen
Floris H. P. van Velden
Alexander L. Vahrmeijer
Rutger-Jan Swijnenburg
J. Sven D. Mieog
Lioe-Fee de Geus-Oei
The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
Diagnostics
positron emission tomography
colorectal cancer
colorectal liver metastases
follow-up
title The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
title_full The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
title_fullStr The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
title_full_unstemmed The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
title_short The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
title_sort value of sup 18 sup f fdg pet ct imaging in treatment evaluation of colorectal liver metastases a systematic review
topic positron emission tomography
colorectal cancer
colorectal liver metastases
follow-up
url https://www.mdpi.com/2075-4418/12/3/715
work_keys_str_mv AT okkerdbijlstra thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT maudmeboreel thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT sietsevanmossel thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT markcburgmans thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT ellenhwkapiteijn thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT danielaeoprealager thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT daphneddrietbergen thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT florishpvanvelden thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT alexanderlvahrmeijer thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT rutgerjanswijnenburg thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT jsvendmieog thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT lioefeedegeusoei thevalueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT okkerdbijlstra valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT maudmeboreel valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT sietsevanmossel valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT markcburgmans valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT ellenhwkapiteijn valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT danielaeoprealager valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT daphneddrietbergen valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT florishpvanvelden valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT alexanderlvahrmeijer valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT rutgerjanswijnenburg valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT jsvendmieog valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview
AT lioefeedegeusoei valueofsup18supffdgpetctimagingintreatmentevaluationofcolorectallivermetastasesasystematicreview